Equities
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)1,487.00
  • Today's Change-26.50 / -1.75%
  • Shares traded8.17m
  • 1 Year change-33.59%
  • Beta0.7222
Data delayed at least 20 minutes, as of May 17 2024 07:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments364,471376,946318,267
Total Receivables, Net548,036465,455423,018
Total Inventory248,738174,386153,072
Prepaid expenses------
Other current assets, total33,48533,16728,997
Total current assets1,194,7301,049,954923,354
Property, plant & equipment, net293,742286,459269,044
Goodwill, net418,694328,411303,030
Intangibles, net1,453,824562,496623,431
Long term investments124,378101,95591,009
Note receivable - long term20,04332,79340,666
Other long term assets18,59810,2819,530
Total assets3,569,6032,456,5182,332,395
LIABILITIES
Accounts payable185,193140,236130,739
Accrued expenses------
Notes payable/short-term debt--75,000140,000
Current portion long-term debt/capital leases472,27813,54617,730
Other current liabilities, total628,254497,252398,942
Total current liabilities1,285,725726,034687,411
Total long term debt447,738111,46155,014
Total debt920,016200,007212,744
Deferred income tax51,3466,0485,823
Minority interest------
Other liabilities, total188,806105,021123,839
Total liabilities1,973,615948,564872,087
SHAREHOLDERS EQUITY
Common stock103,001103,001103,001
Additional paid-in capital184,070181,280179,467
Retained earnings (accumulated deficit)809,400908,694944,891
Treasury stock - common(33783)(25123)(13934)
Unrealized gain (loss)------
Other equity, total533,300340,102246,883
Total equity1,595,9881,507,9541,460,308
Total liabilities & shareholders' equity3,569,6032,456,5182,332,395
Total common shares outstanding1,7931,7971,827
Treasury shares - common primary issue17138.78
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.